�y��vlog

Researchers randomly divided participants into two groups: One received standard care, and the intervention group ate meals provided by the research team for eight weeks.

A certain percentage of patients did not have an actionable tumor variant detected, so they received standard of care.

After adjusting for baseline characteristics, the analysis showed that the genome-matched group was 31% less likely to die within the first year than those who received standard care, even though only 9% were able to participate in a clinical trial, a smaller share than previously reported by other studies and might be explained by the rurality of Maine.

With Burkard, the team studied tumor samples taken from breast cancer patients who received standard anti-microtubule chemotherapy at the UW Carbone Cancer Center.

Trial participants received standard care from medical professionals where necessary, and the virus used was a weakened version to minimise symptoms.